Please login to the form below

Not currently logged in
Email:
Password:

Kite Pharma appoints head of regulatory affairs

Rizwana Sproule joins from Amgen
Kite Pharma Rizwana Sproule

Kite Pharma has appointed former Amgen executive director Dr Rizwana Sproule as head VP, regulatory affairs.

Dr Sproule spent 14 year at Amgen, most recently serving as executive director, therapeutic area head for oncology global regulatory affairs.

In this role, she oversaw Amgen's oncology products having previously held the role of global regulatory leader for the development of Amgen's Vectibix (panitumumab), which is approved to treat colorectal cancer.

Her experience prior to joining Amgen includes a regulatory affairs consultant role at the clinical research organisation (CRO) Kendle, as well as roles at SmithKline Beecham and Syntex.

Kite's chairman Dr Arie Belldegrun said: "Rizwana offers an impressive track record in guiding the regulatory process for well-recognised best-in-class therapies, and her expertise in working with international agencies – FDA, EMA/CHMP, Health Canada, and PMDA – at multiple levels will be critical to Kite's further advancement and planning.”

Dr Sproule is the latest in a string of senior appointments at Kite as the company prepares for the advance of its research projects involving cancer immunotherapies.

Other recent additions include chief financial officer Cynthia Butitta; Dr Keith Nolop as chief medical officer; and several cancer experts to the company's scientific advisory board.

22nd January 2014

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...

Infographics